2Dina R, Jafari M. Angiotensin Ⅱ receptor antagonists: an overview[J]. Am J Health Syst Pharm,2000,57(13) :1231-1241.
3Hemandez R, Velasco M, Armas M J, et al. Angiotensin Ⅱ receptor antagonists in arterial hypertension [J]. J Hum Hypertens,2000,14 (Suppl 1): S69-72.
4Sharpe M, Jarvis B, Goa KL. Telmisartan: a review of its use in hypertension [ J ]. Drugs, 2001,61 ( 10 ): 1501-1529.
5Israili ZH. Clinical pharmacokinetics of angiotensin Ⅱ (AT1)receptor blockers in hypertension [ J ]. J Hum Hypertens,2000,14(Suppl 1 ) :S73-86.
6Neutel JM, Smith DHG, for the Telmisartan US Study Group.Dose response and antihypertensive efficacy of the ATI receptor antagonist telmisartan in patients with mild to moderate hypertension [J]. Adv Ther, 1998,20 (2) :205-221.
7Balt JC, Mathy M J, Nap A, et al. Effect of the AT1-receptor antagonists losartan ,irbesartan, and telmisartan on angiotensin Ⅱinduced facilitation of sympathetic neurotransmission in the rat mesenteric artery [J]. J Cardiovasc Pharmacol, 2001,38 (1):141-148.
8Bumier M, Maillard M. The comparative pharmacology of angiotensin Ⅱ receptor antagonists [J]. Blood Press,2001,10 ( Suppl 1) :6-11.
